-+ 0.00%
-+ 0.00%
-+ 0.00%

Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2

Benzinga·07/07/2026 12:35:05
Listen to the news

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the second quarter ended June 30, 2026, compared to the first quarter ended March 31, 2026.